Ingredient developers need faster and more predictive in-vivo evidence without the cost, time and animal use of conventional mammalian studies.
R&D Focus
AI-powered organism-on-chip screening using C. elegans and microfluidics.
Innovative Solution
The Infinity Screening System automates whole-organism safety, efficacy and performance testing and uses visual AI to quantify biological outcomes.
Solution Effectiveness
The company reports 5 to 1,000 times cost savings and 2 to 25 times faster testing depending on the program. Partner ingredients have advanced into first-in-human trials.
Investment Funding
Last Funding Stage
Series A
Total Funding Amount
$2.25M
Last Funding Amount
$1M
Startup Stage
Early Stage
Lead Investors
National Institute of Aging (NIA), Motif FoodWorks, National Institutes of Health, TTU Accelerator
People
Founders
Siva Vanapalli Ph.D
Mizanur Rahman
Nicki Vanapalli
CEO
Siva Vanapalli
About
NemaLife is a developer of a biotech platform designed to de-risk research and development (R&D) for companies
Products
Product
Infinity Screening System and Discovery Flywheel ingredient-development platform.
Star Product
Infinity Screening System, because it supports both discovery and validation at high throughput.
Demo Product or Complete Product?
Commercial B2B screening and ingredient-development service.
Future Plan
Market Expansion
Expanding from contract screening into internally developed bioactive ingredients and formulations.
Investment Funding
Non-dilutive NIH funding includes a $300,000 probiotics and postbiotics program and other research awards.
Awards and Recognitions
Awards
NutraIngredients Probiota Pioneer, 2023.
Participations
Probiota and nutrition-innovation programs; ingredient discovery programs across multiple categories.
M&A and Collabs
Collab
National Institutes of Health: $300,000 grant for probiotic and postbiotic discovery.
Collab
Ingredient suppliers and consumer-health brands: validation and formulation-development programs.
Something missing or incorrect on this page? Help us enrich this information
